SCHEMBL19976796

SCHEMBL19976796

COC[C@H](C)N/C(=N/C(=O)c1ccc(N2CCOCC2)nc1)Nc1[nH]nc2cc(C(F)(F)F)ccc12

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.43
STAT3 P40763 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
MAPK1 P28482 6/20 0.42
MCHR1 Q99705 2/20 0.38
RAF1 P04049 4/20 0.37
BRAF P15056 4/20 0.37
DGAT1 O75907 1/20 0.37
SOAT1 P35610 1/20 0.37
KCNH2 Q12809 1/20 0.37
MAPK8 P45983 1/20 0.36
ALDH1A1 P00352 1/20 0.36
GAA P10253 1/20 0.36
KDM4E B2RXH2 1/20 0.36
HPGD P15428 1/20 0.36
TSHR P16473 1/20 0.36
CYP1A2 P05177 1/20 0.35
CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19976928 0.82 CTNNB1 (0.37) MAPK1ALDH1A1GAAKDM4EHPGD
SCHEMBL19976944 0.81 MAPK1 (0.36) MAPTSMN1; SMN2MAPK1ALDH1A1KDM4E
SCHEMBL19976798 0.79 PTGES (0.36) MAPTMAPK1ALDH1A1GAAKDM4E
SCHEMBL19976851 0.75 POLB (0.35) MAPTSMN1; SMN2MAPK1ALDH1A1KDM4E
SCHEMBL19976845 0.75 MAPT (0.45) MAPTSTAT3SMN1; SMN2MAPK1RAF1
SCHEMBL19976814 0.73 MAPT (0.47) MAPTSTAT3SMN1; SMN2MAPK1DGAT1
SCHEMBL19976756 0.73 MAPT (0.46) MAPTSTAT3SMN1; SMN2MAPK1DGAT1
SCHEMBL19976833 0.73 HPGD (0.41) MAPTSMN1; SMN2MAPK1ALDH1A1GAA
SCHEMBL19976727 0.73 GSK3B (0.36) MAPTMAPK1
SCHEMBL19976770 0.72 MAPK1 (0.38) MAPK1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9920012-B2 Indazole guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2018-03-20 US disclosed